| Name | Title | Contact Details |
|---|
Marwan M. Shaykh, M.D. is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Heyday is a people-first skincare company, bringing together human touch, expertise, and data to personalize and empower people to take care of their skin. We opened our first retail location in 2015 – taking the facial and indulgence out of the spa, elevating the estheticians as the experts they are, and removing the overwhelm out of building an at-home skincare routine. Today, we have 9 locations in New York, Los Angeles, and Philadelphia. We`ve performed 225,000 facials, collected data on skincare conditions, preferences, and purchases, and become an employer of choice for a world-class team of estheticians we call Heyday Skin Therapists. Our next chapter is to take these ingredients and create unparalleled personalization and guidance across content, communities, recommendations, and services in both our physical stores and our e-commerce experience. `Heyday` means a period of your life when you`re feeling at your best. Above all, we exist to help people achieve their `heyday` – to show up in the world as their best selves, every day. We start with the skin you`re in.
Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.
Rhapsody partners with healthcare organizations around the globe delivering its adaptable Interoperability Suite to reliably connect, classify, and clean data. Rhapsody health solutions power the applications and workflows that improve clinical, operational, and financial outcomes today while helping teams respond to and prepare for changes on the horizon. Rhapsody is committed to empowering people throughout the healthcare ecosystem, from specialty clinics to large care networks, from public health to health technology, and everything in between.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.